SREBF1 and gallbladder carcinoma: Thus, in this study, we hypothesized that α‐mangostin represses de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells by targeting the AMPK/SREBP1 cascades.